Stem Cell Therapeutics Expands Executive Team by Appointing Thomas Franck as Vice President of Commercial Planning

CALGARY, ALBERTA--(Marketwire - May 30, 2008) - Stem Cell Therapeutics Corp. (“SCT”) (TSX VENTURE: SSS) is pleased to announce the appointment of Mr. Thomas Franck as Vice President of Commercial Planning.

MORE ON THIS TOPIC